Careful assessment of the benefit-risk ratio and specific considerations like renal function and fall risk are essential when prescribing anticoagulants to elderly patients to maximize safety.
No takes yet. Share an insight, caveat, or question.
Supports individualized anticoagulant use in elderly patients; leaves open the need for dedicated prospective trials to optimize risk tools.
Marc Righini (2009) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: